Leukoregulin, a novel cytokine enhances the anti-herpesvirus actions of acyclovir

John J. Hooks, Barbara Detrick, Charles H. Evans

Research output: Contribution to journalArticle

Abstract

Leukoregulin is a naturally occurring immunologic cytokine which increases membrane permeability and drug uptake in tumor cells but not in normal cells. In this paper we show that leukoregulin also increases membrane permeability of Herpes simplex virus type 1 (HSV-1)-infected cells. More importantly, we demonstrate that leukoregulin significantly enhances the ability of acyclovir (acycloguanosine, ACV) to inhibit the cellular release of infectious HSV-1. The ability of 1-100 μM ACV to inhibit infectious HSV-1 production is increased up to 100-fold when HSV-1-infected human amnion (WISH) cells are treated with 5 units leukoregulin/ml and ACV 3 hr after virus infection. Under these conditions, leukoregulin alone is unable to inhibit HSV-1 infectivity. In addition, three unrelated cytokines, interleukin-1 α (IL-1), interferon (IFN)-α and IFN-γ lack the ability to enhance the anti-HSV actions of ACV when their treatment is initiated after HSV-1 infection. These findings demonstrate that a combination of immunotherapy and chemotherapy can produce a substantial inhibition of herpesvirus replication and provide a rationale for the application of this approach to the interventive treatment of virus infection.

Original languageEnglish (US)
Pages (from-to)244-253
Number of pages10
JournalClinical Immunology and Immunopathology
Volume60
Issue number2
DOIs
StatePublished - Aug 1991
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Pathology and Forensic Medicine
  • Immunology

Fingerprint Dive into the research topics of 'Leukoregulin, a novel cytokine enhances the anti-herpesvirus actions of acyclovir'. Together they form a unique fingerprint.

  • Cite this